Webcast:

Challenges in the management of nosocomial pneumonia in the post-COVID-19 era

Coming soon
Alt tag

Webcast:

Challenges in the management of nosocomial pneumonia in the post-COVID-19 era

Coming soon

About this webcast

Early appropriate antibiotic therapy reduces morbidity and mortality of severe pneumonia, but selecting the appropriate antibiotic for empirical therapy remains challenging. Join our panel of experts to discuss the challenges they have faced in managing nosocomial pneumonia in their COVID-19 patients.

Coming soon

If you have observed any unwanted or adverse effect, or have a quality complaint related to a Bayer product, we would be interested to hear about it as part of our ongoing pharmacovigilance processes. You may report these to us through our Bayer Side Effect Reporting website.